nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemifloxacin—Retinal haemorrhage—Carmustine—malignant glioma	0.0408	0.0448	CcSEcCtD
Gemifloxacin—Transient ischaemic attack—Temozolomide—malignant glioma	0.0255	0.028	CcSEcCtD
Gemifloxacin—Aphasia—Carmustine—malignant glioma	0.0205	0.0225	CcSEcCtD
Gemifloxacin—Aphasia—Temozolomide—malignant glioma	0.0198	0.0218	CcSEcCtD
Gemifloxacin—Trovafloxacin—TOP2A—malignant glioma	0.018	0.202	CrCbGaD
Gemifloxacin—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.0156	0.0171	CcSEcCtD
Gemifloxacin—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.0141	0.0155	CcSEcCtD
Gemifloxacin—Moxifloxacin—TOP2A—malignant glioma	0.0136	0.153	CrCbGaD
Gemifloxacin—Coordination abnormal—Carmustine—malignant glioma	0.0135	0.0149	CcSEcCtD
Gemifloxacin—Coordination abnormal—Temozolomide—malignant glioma	0.0131	0.0144	CcSEcCtD
Gemifloxacin—Vaginal inflammation—Temozolomide—malignant glioma	0.0128	0.0141	CcSEcCtD
Gemifloxacin—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.0128	0.0141	CcSEcCtD
Gemifloxacin—Skin exfoliation—Carmustine—malignant glioma	0.0127	0.0139	CcSEcCtD
Gemifloxacin—Candida infection—Carmustine—malignant glioma	0.0127	0.0139	CcSEcCtD
Gemifloxacin—Skin exfoliation—Temozolomide—malignant glioma	0.0123	0.0135	CcSEcCtD
Gemifloxacin—Candida infection—Temozolomide—malignant glioma	0.0123	0.0135	CcSEcCtD
Gemifloxacin—Vaginal infection—Temozolomide—malignant glioma	0.0121	0.0133	CcSEcCtD
Gemifloxacin—Abnormal vision—Carmustine—malignant glioma	0.0116	0.0127	CcSEcCtD
Gemifloxacin—Abnormal vision—Temozolomide—malignant glioma	0.0112	0.0123	CcSEcCtD
Gemifloxacin—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.0107	0.0118	CcSEcCtD
Gemifloxacin—Gastroenteritis—Temozolomide—malignant glioma	0.0105	0.0116	CcSEcCtD
Gemifloxacin—Hot flush—Temozolomide—malignant glioma	0.00997	0.0109	CcSEcCtD
Gemifloxacin—Pefloxacin—TOP2A—malignant glioma	0.00995	0.111	CrCbGaD
Gemifloxacin—Menopausal symptoms—Temozolomide—malignant glioma	0.00988	0.0109	CcSEcCtD
Gemifloxacin—Hyponatraemia—Carmustine—malignant glioma	0.00969	0.0106	CcSEcCtD
Gemifloxacin—Face oedema—Carmustine—malignant glioma	0.00932	0.0102	CcSEcCtD
Gemifloxacin—Enoxacin—TOP2A—malignant glioma	0.00931	0.104	CrCbGaD
Gemifloxacin—Face oedema—Temozolomide—malignant glioma	0.009	0.00989	CcSEcCtD
Gemifloxacin—Sparfloxacin—TOP2A—malignant glioma	0.00857	0.0959	CrCbGaD
Gemifloxacin—Breast disorder—Temozolomide—malignant glioma	0.00843	0.00926	CcSEcCtD
Gemifloxacin—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.0084	0.00922	CcSEcCtD
Gemifloxacin—Dysphagia—Carmustine—malignant glioma	0.00834	0.00916	CcSEcCtD
Gemifloxacin—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00823	0.00903	CcSEcCtD
Gemifloxacin—Dysphagia—Temozolomide—malignant glioma	0.00806	0.00885	CcSEcCtD
Gemifloxacin—Hyperglycaemia—Carmustine—malignant glioma	0.00752	0.00826	CcSEcCtD
Gemifloxacin—Pneumonia—Carmustine—malignant glioma	0.00748	0.00821	CcSEcCtD
Gemifloxacin—Photosensitivity reaction—Temozolomide—malignant glioma	0.00736	0.00808	CcSEcCtD
Gemifloxacin—Renal failure—Carmustine—malignant glioma	0.00731	0.00803	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Carmustine—malignant glioma	0.00729	0.00801	CcSEcCtD
Gemifloxacin—Hyperglycaemia—Temozolomide—malignant glioma	0.00727	0.00799	CcSEcCtD
Gemifloxacin—Stomatitis—Carmustine—malignant glioma	0.00725	0.00796	CcSEcCtD
Gemifloxacin—Pneumonia—Temozolomide—malignant glioma	0.00723	0.00794	CcSEcCtD
Gemifloxacin—Infestation NOS—Temozolomide—malignant glioma	0.00719	0.00789	CcSEcCtD
Gemifloxacin—Infestation—Temozolomide—malignant glioma	0.00719	0.00789	CcSEcCtD
Gemifloxacin—Lomefloxacin—TOP2A—malignant glioma	0.00706	0.079	CrCbGaD
Gemifloxacin—Neuropathy peripheral—Temozolomide—malignant glioma	0.00705	0.00774	CcSEcCtD
Gemifloxacin—Stomatitis—Temozolomide—malignant glioma	0.00701	0.00769	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Temozolomide—malignant glioma	0.0068	0.00746	CcSEcCtD
Gemifloxacin—Haemoglobin—Carmustine—malignant glioma	0.00671	0.00737	CcSEcCtD
Gemifloxacin—Haemorrhage—Carmustine—malignant glioma	0.00668	0.00733	CcSEcCtD
Gemifloxacin—Oedema peripheral—Carmustine—malignant glioma	0.00658	0.00722	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Carmustine—malignant glioma	0.00656	0.0072	CcSEcCtD
Gemifloxacin—Haemoglobin—Temozolomide—malignant glioma	0.00649	0.00712	CcSEcCtD
Gemifloxacin—Haemorrhage—Temozolomide—malignant glioma	0.00645	0.00709	CcSEcCtD
Gemifloxacin—Visual impairment—Carmustine—malignant glioma	0.00643	0.00707	CcSEcCtD
Gemifloxacin—Pharyngitis—Temozolomide—malignant glioma	0.0064	0.00703	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Temozolomide—malignant glioma	0.00637	0.007	CcSEcCtD
Gemifloxacin—Oedema peripheral—Temozolomide—malignant glioma	0.00636	0.00698	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Temozolomide—malignant glioma	0.00634	0.00696	CcSEcCtD
Gemifloxacin—Urethral disorder—Temozolomide—malignant glioma	0.00633	0.00695	CcSEcCtD
Gemifloxacin—Eye disorder—Carmustine—malignant glioma	0.00624	0.00685	CcSEcCtD
Gemifloxacin—Visual impairment—Temozolomide—malignant glioma	0.00622	0.00683	CcSEcCtD
Gemifloxacin—Flushing—Carmustine—malignant glioma	0.0062	0.0068	CcSEcCtD
Gemifloxacin—Erythema multiforme—Temozolomide—malignant glioma	0.0061	0.0067	CcSEcCtD
Gemifloxacin—Levofloxacin—TOP2A—malignant glioma	0.00603	0.0675	CrCbGaD
Gemifloxacin—Ofloxacin—TOP2A—malignant glioma	0.00603	0.0675	CrCbGaD
Gemifloxacin—Eye disorder—Temozolomide—malignant glioma	0.00603	0.00662	CcSEcCtD
Gemifloxacin—Flushing—Temozolomide—malignant glioma	0.00599	0.00658	CcSEcCtD
Gemifloxacin—Cardiac disorder—Temozolomide—malignant glioma	0.00599	0.00658	CcSEcCtD
Gemifloxacin—Angiopathy—Temozolomide—malignant glioma	0.00585	0.00643	CcSEcCtD
Gemifloxacin—Mental disorder—Carmustine—malignant glioma	0.00585	0.00642	CcSEcCtD
Gemifloxacin—Immune system disorder—Temozolomide—malignant glioma	0.00583	0.0064	CcSEcCtD
Gemifloxacin—Ciprofloxacin—TOP2A—malignant glioma	0.00582	0.0652	CrCbGaD
Gemifloxacin—Mediastinal disorder—Temozolomide—malignant glioma	0.00582	0.00639	CcSEcCtD
Gemifloxacin—Mental disorder—Temozolomide—malignant glioma	0.00565	0.00621	CcSEcCtD
Gemifloxacin—Back pain—Carmustine—malignant glioma	0.00562	0.00617	CcSEcCtD
Gemifloxacin—Dysgeusia—Temozolomide—malignant glioma	0.0055	0.00604	CcSEcCtD
Gemifloxacin—Tremor—Carmustine—malignant glioma	0.00545	0.00598	CcSEcCtD
Gemifloxacin—Back pain—Temozolomide—malignant glioma	0.00543	0.00597	CcSEcCtD
Gemifloxacin—Anaemia—Carmustine—malignant glioma	0.00537	0.0059	CcSEcCtD
Gemifloxacin—Tremor—Temozolomide—malignant glioma	0.00526	0.00578	CcSEcCtD
Gemifloxacin—Leukopenia—Carmustine—malignant glioma	0.0052	0.00571	CcSEcCtD
Gemifloxacin—Anaemia—Temozolomide—malignant glioma	0.00519	0.0057	CcSEcCtD
Gemifloxacin—Vertigo—Temozolomide—malignant glioma	0.00505	0.00554	CcSEcCtD
Gemifloxacin—Leukopenia—Temozolomide—malignant glioma	0.00503	0.00552	CcSEcCtD
Gemifloxacin—Palpitations—Temozolomide—malignant glioma	0.00496	0.00545	CcSEcCtD
Gemifloxacin—Myalgia—Carmustine—malignant glioma	0.00495	0.00543	CcSEcCtD
Gemifloxacin—Norfloxacin—TOP2A—malignant glioma	0.00489	0.0548	CrCbGaD
Gemifloxacin—Arthralgia—Temozolomide—malignant glioma	0.00478	0.00525	CcSEcCtD
Gemifloxacin—Myalgia—Temozolomide—malignant glioma	0.00478	0.00525	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00475	0.00521	CcSEcCtD
Gemifloxacin—Oedema—Carmustine—malignant glioma	0.00474	0.00521	CcSEcCtD
Gemifloxacin—Dry mouth—Temozolomide—malignant glioma	0.00468	0.00514	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Carmustine—malignant glioma	0.00464	0.0051	CcSEcCtD
Gemifloxacin—Tachycardia—Carmustine—malignant glioma	0.00463	0.00508	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Temozolomide—malignant glioma	0.00458	0.00503	CcSEcCtD
Gemifloxacin—Oedema—Temozolomide—malignant glioma	0.00458	0.00503	CcSEcCtD
Gemifloxacin—Anorexia—Carmustine—malignant glioma	0.00452	0.00497	CcSEcCtD
Gemifloxacin—Nervous system disorder—Temozolomide—malignant glioma	0.0045	0.00494	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Temozolomide—malignant glioma	0.00449	0.00493	CcSEcCtD
Gemifloxacin—Skin disorder—Temozolomide—malignant glioma	0.00445	0.00489	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Temozolomide—malignant glioma	0.00443	0.00487	CcSEcCtD
Gemifloxacin—Anorexia—Temozolomide—malignant glioma	0.00437	0.0048	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00432	0.00475	CcSEcCtD
Gemifloxacin—Insomnia—Carmustine—malignant glioma	0.00429	0.00471	CcSEcCtD
Gemifloxacin—Dyspnoea—Carmustine—malignant glioma	0.00423	0.00464	CcSEcCtD
Gemifloxacin—Somnolence—Carmustine—malignant glioma	0.00422	0.00463	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00418	0.00459	CcSEcCtD
Gemifloxacin—Insomnia—Temozolomide—malignant glioma	0.00415	0.00455	CcSEcCtD
Gemifloxacin—Decreased appetite—Carmustine—malignant glioma	0.00412	0.00453	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Carmustine—malignant glioma	0.0041	0.0045	CcSEcCtD
Gemifloxacin—Dyspnoea—Temozolomide—malignant glioma	0.00409	0.00449	CcSEcCtD
Gemifloxacin—Somnolence—Temozolomide—malignant glioma	0.00408	0.00448	CcSEcCtD
Gemifloxacin—Constipation—Carmustine—malignant glioma	0.00406	0.00445	CcSEcCtD
Gemifloxacin—Pain—Carmustine—malignant glioma	0.00406	0.00445	CcSEcCtD
Gemifloxacin—Dyspepsia—Temozolomide—malignant glioma	0.00404	0.00443	CcSEcCtD
Gemifloxacin—Decreased appetite—Temozolomide—malignant glioma	0.00399	0.00438	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00396	0.00435	CcSEcCtD
Gemifloxacin—Fatigue—Temozolomide—malignant glioma	0.00395	0.00434	CcSEcCtD
Gemifloxacin—Pain—Temozolomide—malignant glioma	0.00392	0.0043	CcSEcCtD
Gemifloxacin—Constipation—Temozolomide—malignant glioma	0.00392	0.0043	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Carmustine—malignant glioma	0.00388	0.00426	CcSEcCtD
Gemifloxacin—Abdominal pain—Carmustine—malignant glioma	0.00375	0.00412	CcSEcCtD
Gemifloxacin—Body temperature increased—Carmustine—malignant glioma	0.00375	0.00412	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Temozolomide—malignant glioma	0.00375	0.00412	CcSEcCtD
Gemifloxacin—Urticaria—Temozolomide—malignant glioma	0.00364	0.004	CcSEcCtD
Gemifloxacin—Abdominal pain—Temozolomide—malignant glioma	0.00362	0.00398	CcSEcCtD
Gemifloxacin—Body temperature increased—Temozolomide—malignant glioma	0.00362	0.00398	CcSEcCtD
Gemifloxacin—Asthenia—Carmustine—malignant glioma	0.0034	0.00374	CcSEcCtD
Gemifloxacin—Asthenia—Temozolomide—malignant glioma	0.00329	0.00361	CcSEcCtD
Gemifloxacin—Diarrhoea—Carmustine—malignant glioma	0.00325	0.00356	CcSEcCtD
Gemifloxacin—Pruritus—Temozolomide—malignant glioma	0.00324	0.00356	CcSEcCtD
Gemifloxacin—Dizziness—Carmustine—malignant glioma	0.00314	0.00344	CcSEcCtD
Gemifloxacin—Diarrhoea—Temozolomide—malignant glioma	0.00314	0.00344	CcSEcCtD
Gemifloxacin—Dizziness—Temozolomide—malignant glioma	0.00303	0.00333	CcSEcCtD
Gemifloxacin—Vomiting—Carmustine—malignant glioma	0.00302	0.00331	CcSEcCtD
Gemifloxacin—Rash—Carmustine—malignant glioma	0.00299	0.00328	CcSEcCtD
Gemifloxacin—Dermatitis—Carmustine—malignant glioma	0.00299	0.00328	CcSEcCtD
Gemifloxacin—Headache—Carmustine—malignant glioma	0.00297	0.00326	CcSEcCtD
Gemifloxacin—Vomiting—Temozolomide—malignant glioma	0.00291	0.0032	CcSEcCtD
Gemifloxacin—Rash—Temozolomide—malignant glioma	0.00289	0.00317	CcSEcCtD
Gemifloxacin—Dermatitis—Temozolomide—malignant glioma	0.00289	0.00317	CcSEcCtD
Gemifloxacin—Headache—Temozolomide—malignant glioma	0.00287	0.00315	CcSEcCtD
Gemifloxacin—Nausea—Carmustine—malignant glioma	0.00282	0.00309	CcSEcCtD
Gemifloxacin—Nausea—Temozolomide—malignant glioma	0.00272	0.00299	CcSEcCtD
